What Big Pharma Can Learn from BiotechsJohn Capodanno
Big Pharma is Good This section below is a bit of a rant but needs to happen. Today Big Pharma takes such a negative hit in the news. Not a day goes by that I see yet another feed or article on how slimy Pharma has become. We need to focus on stopping the blame. Sure Pharma is...
career or life that they must pay attention to. They should consider what you’re offering as a new, superior way of doing things. This is how you get your prospect’s attention, and it shows that you truly understand them, focusing on their needs rather than yours (making them a lead)...
First, is the treatment FDA approved and if not, why not? Second, can you please show me the data that proves your treatment is safe and effective? See what kind of answer you get. If they criticize the FDA or invoke a plot by “big pharma” to block stem cells then that is a wa...
A building management system (BMS) is a control system that can be used to monitor and manage the mechanical, electrical and electromechanical systems and services in a facility. Such services include power; heating, ventilation and air conditioning (HVAC); physical access control; fire safety syst...
Pharmaceutical detailing is a 1:1 marketing technique pharmaceutical companies use to educate a physician about a vendor's products, hoping that the physician will prescribe the company's products more often. Although this practice is controversial, many drug companies spend billions of dollars a year...
January 08, 2025 PublicationsAI & Drug Discovery – Risk Profiles from Startups to Big Pharma December 19, 2024 PublicationsWhat is the IP Risk Profile in AI Drug Discovery? December 18, 2024 PublicationsSome AI-Discovered Drugs Carry More IP Risks Than Others—Here's Why ...
Biotech Definition Biotechnology, or biotech, is technology that uses living organisms and biological systems to create products and services, typically with healthcare and industrial applications. What Is Biotech? Biotech vs. Biopharma Types Of Biotech ...
This move towards specialization is especially evident in the pharmaceutical industry. As far as drugmakers are concerned, corporations that do not specialize are doomed. Big pharma has been going through a very rough time, with assaults from generic drug manufacturers, the rise of low-cost drug...
ETFscan be useful assets for traders. These assets have more volatility, and traders try to capitalize on short-term price movements as they seek profits. Gains and losses both get magnified. This type of atmosphere can help traders realize more gains, of course, but the opposite ...